B0B925 AF NFT

Glycogen synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifce5elyfgr3kkaqjl6hl3cx6f5qjv6tysocnxqegwqk4icgjnbtm/metadata.json
IPFS of structure file: 
bafybeihoi7v2hxlmnuoq7ewudfqbspzvjvar7rm36hv5kirlaofufxbn4m/AF-B0B925-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x62E4f3F90A4E2178090239FF3a4f1bd92B49d52b
First NFT owner address (bech32): 
genesis1vtj087g2fcshszgz88ln5ncmmy45n4fthpt3za
Current NFT ID #148043 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
148043
Accession (UniProt):
B0B925
Name::
Glycogen synthase
Experimental Method:
Predicted structure
Sequence source:
CHLAMYDIA TRACHOMATIS SEROVAR L2 (STRAIN 434/BU / ATCC VR-902B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B0B925 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B0B925|GLGA_CHLT2 Glycogen synthase OS=Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) OX=471472 GN=glgA PE=3 SV=1 MKIIHTAIEFAPVIKAGGLGDALYGLAKALAANHTTEVVIPLYPKLFTLPKEQDLCSIQKLSYFFAGEQEATAFSYFYEGIKVTLFKLDTQPELFENAETIYTSDDAFRFCAFSAAAASYIQKEGANIVHLHDWHTGLVAGLLKQQPCSQLQKIVLTLHNFGYRGYTTREILEASSLNEFYISQYQLFRDPQTCVLLKGALYCSDFVTTVSPTYAKEILEDYSDYEIHDAITARQHHLRGILNGIDTTIWGPETDPNLAKNYTKELFETPSIFFEAKAENKKALYERLGLSLEHSPCVCIISRIAEQKGPHFMKQAILHALENAYTLIIIGTCYGNQLHEEFANLQESLANSPNVRILLTYSDVLARQIFAAADMICIPSMFEPCGLTQMIGMRYGTVPLVRATGGLADTVANGINGFSFFNPHDFYEFRNMLLEAVTTYRTNHDKWQHIVRACLNFSSDLETAANKYLEIYKQ